Grifols SA, Barcelona (GRFS) Upgraded to “Sell” at BidaskClub

BidaskClub upgraded shares of Grifols SA, Barcelona (NASDAQ:GRFS) from a strong sell rating to a sell rating in a report issued on Wednesday.

GRFS has been the topic of several other reports. Zacks Investment Research downgraded shares of Grifols SA, Barcelona from a buy rating to a hold rating in a research report on Wednesday, October 11th. Citigroup started coverage on shares of Grifols SA, Barcelona in a report on Tuesday, October 31st. They set a buy rating on the stock. Finally, UBS downgraded shares of Grifols SA, Barcelona from an outperform rating to a market perform rating in a report on Friday, November 24th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of $24.00.

Shares of Grifols SA, Barcelona (GRFS) traded down $0.14 during mid-day trading on Wednesday, reaching $21.95. 193,900 shares of the company traded hands, compared to its average volume of 620,540. Grifols SA, Barcelona has a one year low of $15.47 and a one year high of $24.20. The stock has a market cap of $15,083.56, a P/E ratio of 20.45, a price-to-earnings-growth ratio of 1.66 and a beta of 1.04. The company has a quick ratio of 1.39, a current ratio of 3.17 and a debt-to-equity ratio of 1.69.

A number of institutional investors and hedge funds have recently made changes to their positions in GRFS. Harding Loevner LP boosted its stake in Grifols SA, Barcelona by 477.5% during the third quarter. Harding Loevner LP now owns 89,561,714 shares of the biotechnology company’s stock worth $272,368,000 after buying an additional 74,051,933 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Grifols SA, Barcelona by 14,219.5% in the second quarter. Ameriprise Financial Inc. now owns 1,901,199 shares of the biotechnology company’s stock valued at $40,153,000 after acquiring an additional 1,887,922 shares in the last quarter. Westpac Banking Corp bought a new stake in shares of Grifols SA, Barcelona in the third quarter valued at about $9,767,000. JPMorgan Chase & Co. raised its holdings in shares of Grifols SA, Barcelona by 13.1% in the second quarter. JPMorgan Chase & Co. now owns 2,178,611 shares of the biotechnology company’s stock valued at $46,035,000 after acquiring an additional 252,169 shares in the last quarter. Finally, GABELLI & Co INVESTMENT ADVISERS INC. raised its holdings in shares of Grifols SA, Barcelona by 795.2% in the third quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 263,175 shares of the biotechnology company’s stock valued at $5,761,000 after acquiring an additional 233,775 shares in the last quarter. Institutional investors own 22.50% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Grifols SA, Barcelona (GRFS) Upgraded to “Sell” at BidaskClub” was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.com-unik.info/2017/12/21/grifols-sa-barcelona-grfs-upgraded-to-sell-at-bidaskclub.html.

Grifols SA, Barcelona Company Profile

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics.

What are top analysts saying about Grifols SA Barcelona? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Grifols SA Barcelona and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit